---
title: "Bridgebio Continues Long Term Debt Management Strategy And Announces Proposed Offering Of Convertible Senior Notes"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/272601932.md"
datetime: "2026-01-14T21:03:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272601932.md)
  - [en](https://longbridge.com/en/news/272601932.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272601932.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/272601932.md) | [繁體中文](https://longbridge.com/zh-HK/news/272601932.md)


# Bridgebio Continues Long Term Debt Management Strategy And Announces Proposed Offering Of Convertible Senior Notes

Jan 14 (Reuters) - BridgeBio Pharma Inc (BBIO.O) : \* BRIDGEBIO CONTINUES LONG TERM DEBT MANAGEMENT STRATEGY AND ANNOUNCES PROPOSED OFFERING OF CONVERTIBLE SENIOR NOTES DUE 2033 TO PREFUND REPAYMENT OF CONVERTIBLE SENIOR NOTES DUE 2027 \* BRIDGEBIO PHARMA INC - TO OFFER $550 MILLION CONVERTIBLE SENIOR NOTES DUE 2033 \* BRIDGEBIO PHARMA INC - PROCEEDS TO REPURCHASE OR REPAY 2027 NOTES Source text: Further company coverage: (BBIO.O)

### Related Stocks

- [BridgeBio Pharma, Inc. (BBIO.US)](https://longbridge.com/en/quote/BBIO.US.md)

## Related News & Research

- [Assenagon Asset Management S.A. Decreases Stock Position in BridgeBio Pharma, Inc. $BBIO](https://longbridge.com/en/news/281143495.md)
- [Nisa Investment Advisors LLC Sells 4,667 Shares of BridgeBio Pharma, Inc. $BBIO](https://longbridge.com/en/news/263882498.md)
- [Upstream Bio Launches $150 Million At-The-Market Program](https://longbridge.com/en/news/280691247.md)
- [Bio Green Med Highlights 2025 Transition and Improved Results](https://longbridge.com/en/news/281086387.md)
- [Bio-Techne’s New COMET Spatial Tools Might Change The Case For Investing In Bio-Techne (TECH)](https://longbridge.com/en/news/281130215.md)